Interestingly shRNA-mediated PRMT1 knockdown concomitant with the expression of FUS increased the cytoplasmic localization of ALS-linked FUS mutants, while the pretreatment with a global methyltransferase inhibitor reduced that in primary motor neuron. This evidence concerns the gene PRMT1 and amyotrophic lateral sclerosis.